Key points are not available for this paper at this time.
The noninferiority of a briefer yet comprehensive treatment for BPD has potential to reduce barriers to treatment access.
McMain et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: